Requip is the first drug approved for restless legs syndrome
June 2005
Requip is the first drug approved for restless legs syndrome.
About 10% of Americans get these overpowering urges to move their legs...especially when at rest.
Ropinirole (Requip) is a dopamine agonist...similar to pramipexole and pergolide. They're thought to help by boosting dopamine, a neurotransmitter responsible for controlling movement.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote